• No results found

Molecular markers of breast cancer metastasis - List of publications

N/A
N/A
Protected

Academic year: 2021

Share "Molecular markers of breast cancer metastasis - List of publications"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Molecular markers of breast cancer metastasis

Weigelt, B.

Publication date

2005

Link to publication

Citation for published version (APA):

Weigelt, B. (2005). Molecular markers of breast cancer metastasis.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s)

and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open

content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please

let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material

inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter

to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You

will be contacted as soon as possible.

(2)

List of publications

List of publications

Bosma AJ, Weigelt B, Lambrechts AC, Verhagen OJ, Pruntel R, Hart AA, Rodenhuis S, van 't Veer LI. Detection of circulating breast tumor cells by differential expression of marker genes. Clin Cancer Res 8, 1871-7, 2002

Weigelt B, Bosma AJ, Hart AAM, Rodenhuis S, van 't VeerLJ. Marker genes for circulating

tumor cells predict survival in metastasized breast cancer patients. Br J Cancer 88, 1091-4, 2003

van 't Veer LJ and Weigelt B. Road map to metastasis. Nature Med 9, 999-1000, 2003

Weigelt B, Bosma AJ, van 't Veer LJ. Expression of a novel lacrimal gland gene, Lacritin, in

human breast tissues. J Cancer Res Clin Oncol 129, 735-6, 2003

Weigelt B, Glas AM, Lodewyk FA, Witteveen AT, Peterse JL, van 't Veer LJ. Gene

expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 100, 15901-5, 2003

Weigelt B, Verduijn P, Bosma AJ, Rutgers EJ, Peterse JL, van 't Veer LJ. Detection of

micrometastatic disease in axillary and sentinel lymph nodes of breast cancer patients by multiple mRNA markers. Br J Cancer 90, 1531-7, 2004

Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M, Kerkhoven RM, Madiredjo M, Nijkamp W, Weigelt B, Agami R, Ge W, Cavet G, Linsley PS, Beijersbergen RL, Bernards R. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431-7, 2004

Theodorou V, Boer M, Weigelt B, Jonkers J, van der Valk M, Hilkens J. FGF10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Oncogene 23, 6047-55, 2004

Weigelt B and van 't Veer LJ. Hard-wired genotype in metastatic breast cancer. Cell Cycle

3, 756-7, 2004

Weigelt B, Peterse JL and van 't Veer LJ. Breast cancer metastasis: markers and models.

Nat Rev Cancer 5, Aug, 2005

(3)

List of publications

Weigelt B, Wessels LFA, Bosma AJ, Glas AM, Nuyten DSA, He YD, Dai H, Peterse JL and

van 't Veer U. No common denominator for breast cancer lymph node metastasis. Under revision, Br J Cancer

Weigelt B, Hu Z, He X, Livasy G, Carey LA, Ewend MG, Glas AM, Perou CM and van 't

Veer LJ. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Submitted for publication

Referenties

GERELATEERDE DOCUMENTEN

Eighty women (40 with a fetus in breech presentation and 40 with a fetus in cephalic presentation) with a gestational age from 36 weeks onwards were offered scenarios

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly

Chapter 3 Clinical factors to predict the outcome of external cephalic version: a meta-analysis. American Journal of Obstetrics & Gynecology 2008 May 23; epub ahead

Maternal outcomes at 2 years after planned cesarean section versus planned vaginal birth for breech presentation at term: the international randomized Term Breech Trial. Outcomes

Potential prognostic factors that varied between the cases were parity, maternal body mass index, engagement of the fetus, amniotic fluid, fetal growth, fetal presentation

Our systematic review showed that several clinical characteristics are predictive for a successful ECV: multiparity (P ≥1), non engagement, a relaxed uterus, a

The importance of our review is that posterior placental localisation, normal amniotic fluid and complete breech position were each factors that, based on systematic review of the

To estimate the effectiveness of nifedipine as a uterine relaxant during external cephalic version (ECV) to correct breech